Filing Flows

Filing Flows › Companies › HeartSciences › Cash flow

HeartSciences cash flow, quarter by quarter

Latest: Q1 FY27 · from the cash-flow statements filed with the SEC

Free cash flow−$1.3M in Q1 FY27 · −$6.8M over twelve months

Operating cash flow−$1.3M
Free cash flow−$1.3M

Analysis

In Q1 FY27, HeartSciences generated −$1.3M of operating cash flow. That is $635K more than in Q1 FY26 (−$2.0M).

Over the twelve months to Jul 31, 2026, operating cash flow was −$6.8M; the largest uses were operating cash flow ($6.8M), other investing ($324K); besides operations, cash came from other financing ($4.2M), shares issued ($183K); the cash balance fell by $2.8M.

Operating cash flow was −$1.3M against net income of −$3.2M. The largest differences: stock-based pay +$739K, payables +$704K, prepaid and other assets +$68K.

Free cash flow

HeartSciences: free cash flow by quarterHeartSciences: free cash flow by quarter−$2.2MQ2 FY25−$1.6MQ3 FY25−$1.6MQ4 FY25−$2.0MQ1 FY26−$2.3MQ2 FY26−$1.5MQ3 FY26−$1.7MQ4 FY26−$1.3MQ1 FY27
Operating cash flow less capital spending.
HeartSciences: operating cash flow against capital spendingHeartSciences: operating cash flow against capital spendingOperating cash flowCapital spending−$2.2M$0Q2 FY25−$1.6M$0Q3 FY25−$1.6M$0Q4 FY25−$2.0M$0Q1 FY26−$2.3M$0Q2 FY26−$1.5M−$9KQ3 FY26−$1.7M$0Q4 FY26−$1.3M$0Q1 FY27
Latest (Q1 FY27): Operating cash flow −$1.3M, Capital spending $0.

Capital allocation, year by year

HeartSciences: where the cash came from (up) and went (down), by fiscal yearHeartSciences: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY22: Operating cash flow −$3.6MFY22: Net borrowing $4.2MFY22: Capital spending −$2K$4.2MFY22FY23: Operating cash flow −$5.8MFY23: Net borrowing −$398KFY23: Shares issued $5.2MFY23: Capital spending −$18K$5.2MFY23FY24: Operating cash flow −$6.1MFY24: Net borrowing −$292KFY24: Capital spending −$64KFY24FY25: Operating cash flow −$7.4MFY25: Shares issued $1.1MFY25: Capital spending −$3K$1.1MFY25FY26: Operating cash flow −$7.4MFY26: Shares issued $173KFY26: Capital spending −$4K$173KFY26
Over these 5 years operating cash flow totalled −$30.3M; the largest uses were operating cash flow ($30.3M) and net borrowing ($690K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$30K
Debtnone
Net cash$30K
Cash runway0 months

HeartSciences is burning cash: its operations consume cash, a free cash flow of −$6.8M a year at the current rate against $30K of cash and investments: a runway of about 0 months before any new financing.

Where the cash came from and went

HeartSciences: sources (+) and uses (−) of cash, Q1 FY27HeartSciences: sources (+) and uses (−) of cash, Q1 FY27Cash drawn (+) / kept (−)$1.6MOperating cash flow−$1.3MOther investing−$280KOther financing−$38KShares issued$10K
HeartSciences: sources (+) and uses (−) of cash, TTM to Q1 FY27HeartSciences: sources (+) and uses (−) of cash, TTM to Q1 FY27Operating cash flow−$6.8MOther financing$4.2MCash drawn (+) / kept (−)$2.8MOther investing−$324KShares issued$183K

From profit to cash

HeartSciences: net income to operating cash flow, Q1 FY27HeartSciences: net income to operating cash flow, Q1 FY27Net income−$3.2MDepreciation & amortization$6KStock-based pay$739KInventory$1KPayables$704KAccrued liabilities−$35KPrepaid and other assets$68KOperating cash flow−$1.3M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q1 FY27−$1.3M——$10K$1.6M−$1.3M
Q4 FY26−$1.7M———$1.7M−$1.7M
Q3 FY26−$1.5M$9K——−$1.4M−$1.5M
Q2 FY26−$2.3M—−$350K—$841K−$2.3M
Q1 FY26−$2.0M—−$100K—−$1.7M−$2.0M
Q4 FY25−$1.6M——$171K$1.5M−$1.6M
Q3 FY25−$1.6M———$1.5M−$1.6M
Q2 FY25−$2.2M—−$70K—$288K−$2.2M

HeartSciences: income statement and cash flow

HeartSciences, Q1 FY27: revenue $2K (+10% year over year). The chart follows the revenue to costs, profit and cash.

HeartSciences: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.